Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.60
+0.79002.48%
Post-market: 32.55-0.0542-0.17%18:34 EDT
Volume:6.99M
Turnover:227.98M
Market Cap:3.80B
PE:-6.98
High:33.29
Open:31.86
Low:31.20
Close:31.81
52wk High:43.15
52wk Low:25.77
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.47
T/O Rate:6.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.31
PE(LYR):-10.21

Loading ...

Viking Therapeutics Raises Capital via Equity and Convertibles

TIPRANKS
·
Sep 29

Viking Therapeutics Closes USD 292.5 Million Convertible Senior Notes Offering

Reuters
·
Sep 29

Press Release: Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes

Dow Jones
·
Sep 29

Viking Therapeutics Rallies as Obesity Drug Hopes Rise

TIPRANKS
·
Sep 26

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

TIPRANKS
·
Sep 25

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Reuters
·
Sep 24

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Falls 14.12% in Regular Trading, $400 Million Dual Offering Sparks Dilution Concerns After Sharp Rally

Market Focus
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
Sep 24

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Falls 8.8% in Pre-Market Trading, $400 Million Dual Equity and Convertible Notes Offering Sparks Dilution Concerns

Market Focus
·
Sep 24

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

TIPRANKS
·
Sep 24

Viking Therapeutics Slips on Planned Stock, Convertible Offerings

Reuters
·
Sep 24

Movement Alert|Viking Therapeutics Falls 8.3% in After-Hours Trading, Profit-Taking Emerges After Two-Day Rally on Obesity Drug Data

Market Focus
·
Sep 24

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Sep 24

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS
·
Sep 24

Movement Alert|Viking Therapeutics Rises 5.31% in Regular Trading, Obesity Drug VK2735 Maintenance Data Continues to Fuel Rally

Market Focus
·
Sep 24